Anzupgo (Delgocitinib)

 Anzupgo (delgocitinib) cream is a topical pan-Janus kinase (JAK) inhibitor used for the topical treatment of moderate to severe chronic hand eczema (CHE) in adults who have had an inadequate response to, or for whom, topical corticosteroids are not advisable. It inhibits the activation of JAK-STAT signaling, which plays a key role in the pathogenesis of CHE.

Limitations of Use: Use of this therapeutic drug in combination with other JAK inhibitors or potent immunosuppressants is not recommended.

Recommended Dosage:
The recommended dosage should not be more than 30 grams per 2 weeks or 60 grams per month. Prior to applying this cream, clean and dry the affected areas. Apply a thin layer of Anzupgo twice daily to the affected areas only on the hands and wrists. This therapeutic drug is for topical use only. Not for oral, ophthalmic, or intravaginal use. Avoid contact with eyes, mouth, or other mucous membranes. If contact with mucous membranes occurs, rinse thoroughly with water.

• Treatment with Delgocitinib cream may increase the risk of serious infections, particularly in individuals with weak immunity. Avoid using the cream on infected skin areas. Report any fever, persistent cough, or unusual symptoms immediately. Your healthcare provider (HCP) may recommend monitoring for infection signs during treatment.
• Rarely, use of this cream may be related to certain skin cancers such as basal cell carcinoma or squamous cell carcinoma. Regularly check your skin for any unusual growths, sores, or changes in moles, and report them promptly to your healthcare provider.
• Avoid live vaccines while on treatment with Delgocitinib, as it may be responsible for reducing vaccine effectiveness or increasing infection risk. Discuss your past history of vaccination with your clinician before starting treatment. Inactivated vaccines may still be administered, but your doctor should determine based on your health condition.
• Delgocitinib is a Janus kinase (JAK) inhibitor, and its long-term use may predispose some patients to blood clots, particular malignancies, and cardiovascular events. Inform the doctor of the entire medical history prior to use. Some patients may require close observation in order to identify the complications early.
• There is not much information available about the safety of this medicine during pregnancy. It should only be used if the potential benefit justifies possible risks to the unborn baby. Pregnant women should consult their healthcare provider (HCP) before starting or continuing treatment with this medicine.
• It is not known if Delgocitinib passes into breast milk. To avoid any potential harm to a nursing baby, your clinician may advise avoiding breastfeeding while using the cream or stopping the medicine. Always discuss options with your healthcare provider (HCP) before deciding

What documents are required to import ANZUPGO to India?

ANZUPGO (delgocitinib) cream can be imported by patients or government hospitals in the name of the patients only.

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is ANZUPGO available in India?

ANZUPGO (delgocitinib cream) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Anzupgo in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

ANZUPGO can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of ANZUPGO (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork-in-253190.hostingersite.com for Anzupgo 20 mg cream price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source ANZUPGO (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Anzupgo®?

Delgocitinib is the Generic Name for the trade name drug Anzupgo®.

What is the Manufacturer’s Name of Anzupgo®?

Anzupgo® is manufactured by LEO Laboratories Ltd.

Is Anzupgo approved by the FDA?

Yes, Anzupgo is approved by the FDA. Date of first approval: July 23, 2025.

What is the dosage and form of Anzupgo® supplied?

Anzupgo is supplied in cream containing 20 mg of delgocitinib for topical use.

What are the most common side effects of Anzupgo® 20 mg Cream?

The most commonly reported side effects of Anzupgo® 20 mg are application site pain, pruritus, paresthesia, erythema, and bacterial skin infection,s including finger cellulitis, paronychia, other skin infections, leukopenia, and neutropenia.

How much does Anzupgo® 20 mg Cream cost in India?

Anzupgo® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Prices of Anzupgo Cream may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Anzupgo 20 mg cost in India, please call/WhatsApp +91-92010090915 or send an email to info@indianpharmanetwork-in-253190.hostingersite.com.

Can Anzupgo® 20 mg Cream be available in SAARC countries?

Apart from Gulf countries, Anzupgo® can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Anzupgo® Cream in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Anzupgo® 20 mg Cream online in India?

Yes, one can buy Anzupgo 20 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the legal supply of Anzupgo® Cream through legal channels.

What are the storage conditions of Anzupgo® 20 mg Cream?

Store this cream at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F). Do not freeze.